Cargando…
A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
Dysregulation of the Wnt/β-catenin signaling pathway is critically involved in gastric cancer (GC) progression. However, current Wnt pathway inhibitors being studied in preclinical or clinical settings for other cancers such as colorectal and pancreatic cancers are either too cytotoxic or insufficie...
Autores principales: | Yu, Zeyuan, Jiang, Xiangyan, Qin, Long, Deng, Haixiao, Wang, Jianli, Ren, Wen, Li, Hongbin, Zhao, Lei, Liu, Huanxiang, Yan, Hong, Shi, Wengui, Wang, Qi, Luo, Changjiang, Long, Bo, Zhou, Huinian, Sun, Hui, Jiao, Zuoyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862066/ https://www.ncbi.nlm.nih.gov/pubmed/33323973 http://dx.doi.org/10.1038/s41388-020-01572-w |
Ejemplares similares
-
UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2017) -
Correction: UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2023) -
Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer
por: Shi, Wengui, et al.
Publicado: (2021) -
Pancreatic fistula after pancreatoduodenectomy due to compression of the superior mesenteric vessels: a case report
por: Yang, Hanteng, et al.
Publicado: (2020) -
Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer
por: Qin, Long, et al.
Publicado: (2022)